Oil & Gas Exploration & Production
Build Your Comparison
Side-by-side financial analysisStock Comparison
MXC vs XOM vs CVX vs COP vs DVN vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Exploration & Production
Oil & Gas Exploration & Production
Banks - Diversified
MXC vs XOM vs CVX vs COP vs DVN vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production | Banks - Diversified |
| Market Cap | $16M | $584.04B | $346.46B | $131.32B | $26.18B | $908.57B |
| Revenue (TTM) | $7M | $323.90B | $184.43B | $58.31B | $12.24B | $280.33B |
| Net Income (TTM) | $1M | $28.84B | $12.30B | $7.32B | $2.15B | $57.05B |
| Gross Margin | 35.0% | 21.7% | 30.4% | 29.2% | 21.8% | 60.0% |
| Operating Margin | 21.7% | 10.5% | 9.0% | 18.3% | 18.9% | 25.9% |
| Forward P/E | 9.8x | 12.5x | 12.1x | 10.6x | 7.5x | 14.6x |
| Total Debt | $127K | $43.54B | $46.74B | $23.44B | $8.78B | $942.38B |
| Cash & Equiv. | $2M | $10.68B | $6.47B | $6.50B | $1.43B | $343.34B |
MXC vs XOM vs CVX vs COP vs DVN vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Mexco Energy Corpor… (MXC) | 100 | 241.2 | +141.2% |
| Exxon Mobil Corpora… (XOM) | 100 | 308.2 | +208.2% |
| Chevron Corporation (CVX) | 100 | 194.6 | +94.6% |
| ConocoPhillips (COP) | 100 | 256.4 | +156.4% |
| Devon Energy Corpor… (DVN) | 100 | 371.4 | +271.4% |
| JPMorgan Chase & Co. (JPM) | 100 | 345.8 | +245.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MXC vs XOM vs CVX vs COP vs DVN vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MXC is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 11.4%, EPS growth 30.6%, 3Y rev CAGR 3.8%
- Lower volatility, beta -0.87, Low D/E 0.7%, current ratio 5.48x
- 11.4% revenue growth vs CVX's -4.6%
- Lower D/E ratio (0.7% vs 260.0%)
Among these 6 stocks, XOM doesn't own a clear edge in any measured category.
CVX ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 38 yrs, beta -0.32, yield 4.0%
- Beta -0.32, yield 4.0%, current ratio 1.15x
- 4.0% yield, 38-year raise streak, vs XOM's 2.9%
COP doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
DVN carries the broadest edge in this set and is the clearest fit for value and momentum.
- Lower P/E (7.5x vs 14.6x)
- +26.8% vs MXC's -38.9%
- 9.1% ROA vs JPM's 1.3%, ROIC 12.3% vs 4.5%
JPM is the clearest fit if your priority is long-term compounding.
- 481.2% 10Y total return vs COP's 197.2%
- 20.4% margin vs CVX's 6.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.4% revenue growth vs CVX's -4.6% | |
| Value | Lower P/E (7.5x vs 14.6x) | |
| Quality / Margins | 20.4% margin vs CVX's 6.7% | |
| Stability / Safety | Lower D/E ratio (0.7% vs 260.0%) | |
| Dividends | 4.0% yield, 38-year raise streak, vs XOM's 2.9% | |
| Momentum (1Y) | +26.8% vs MXC's -38.9% | |
| Efficiency (ROA) | 9.1% ROA vs JPM's 1.3%, ROIC 12.3% vs 4.5% |
MXC vs XOM vs CVX vs COP vs DVN vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MXC vs XOM vs CVX vs COP vs DVN vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 2 of 6 categories
MXC leads 2 • XOM leads 0 • CVX leads 0 • COP leads 0 • DVN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 46789.9x MXC's $7M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to CVX's 6.7%. On growth, XOM holds the edge at -1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7M | $323.9B | $184.4B | $58.3B | $12.2B | $280.3B |
| EBITDAEarnings before interest/tax | $4M | $59.9B | $37.1B | $22.4B | $5.0B | $81.4B |
| Net IncomeAfter-tax profit | $1M | $28.8B | $12.3B | $7.3B | $2.1B | $57.0B |
| Free Cash FlowCash after capex | $4M | $23.6B | $16.2B | $18.3B | $2.1B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +35.0% | +21.7% | +30.4% | +29.2% | +21.8% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +21.7% | +10.5% | +9.0% | +18.3% | +18.9% | +25.9% |
| Net MarginNet income ÷ Revenue | +18.1% | +8.9% | +6.7% | +12.6% | +17.6% | +20.4% |
| FCF MarginFCF ÷ Revenue | +56.6% | +7.3% | +8.8% | +31.4% | +16.8% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -26.8% | -1.3% | -5.3% | -2.5% | -99.9% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -90.9% | -11.0% | -24.5% | -20.2% | -100.0% | +16.0% |
Valuation Metrics
MXC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 9.8x trailing earnings, MXC trades at a 63% valuation discount to CVX's 26.2x P/E. On an enterprise value basis, MXC's 3.3x EV/EBITDA is more attractive than JPM's 18.5x.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $16M | $584.0B | $346.5B | $131.3B | $26.2B | $908.6B |
| Enterprise ValueMkt cap + debt − cash | $15M | $616.9B | $386.7B | $148.3B | $33.5B | $1.51T |
| Trailing P/EPrice ÷ TTM EPS | 9.77x | 20.57x | 26.19x | 16.97x | 10.03x | 16.22x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.55x | 12.14x | 10.59x | 7.49x | 14.60x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — | 0.92x |
| EV / EBITDAEnterprise value multiple | 3.31x | 10.29x | 10.42x | 6.40x | 4.51x | 18.52x |
| Price / SalesMarket cap ÷ Revenue | 2.20x | 1.80x | 1.88x | 2.24x | 1.53x | 3.25x |
| Price / BookPrice ÷ Book value/share | 0.89x | 2.23x | 1.68x | 2.09x | 1.71x | 2.51x |
| Price / FCFMarket cap ÷ FCF | 18.97x | 24.73x | 20.88x | 7.83x | 8.39x | 9.01x |
Profitability & Efficiency
MXC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
DVN delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $6 for MXC. MXC carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), MXC scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.5% | +10.7% | +7.2% | +11.3% | +18.6% | +15.9% |
| ROA (TTM)Return on assets | +6.1% | +6.4% | +4.2% | +6.0% | +9.1% | +1.3% |
| ROICReturn on invested capital | +9.1% | +8.6% | +6.2% | +10.4% | +12.3% | +4.5% |
| ROCEReturn on capital employed | +9.7% | +8.9% | +6.6% | +10.4% | +13.8% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 5 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.01x | 0.16x | 0.24x | 0.36x | 0.57x | 2.60x |
| Net DebtTotal debt minus cash | -$2M | $32.9B | $40.3B | $16.9B | $7.3B | $599.0B |
| Cash & Equiv.Liquid assets | $2M | $10.7B | $6.5B | $6.5B | $1.4B | $343.3B |
| Total DebtShort + long-term debt | $126,525 | $43.5B | $46.7B | $23.4B | $8.8B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 666.44x | 69.44x | 17.22x | 9.42x | 7.98x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $25,942 today (with dividends reinvested), compared to $10,479 for MXC. Over the past 12 months, DVN leads with a +26.8% total return vs MXC's -38.9%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs MXC's -12.0% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -19.6% | +14.0% | +13.7% | +13.2% | +12.7% | +0.8% |
| 1-Year ReturnPast 12 months | -38.9% | +25.4% | +21.9% | +18.4% | +26.8% | +20.9% |
| 3-Year ReturnCumulative with dividends | -31.8% | +45.6% | +26.0% | +15.7% | -4.0% | +138.8% |
| 5-Year ReturnCumulative with dividends | +4.8% | +159.4% | +98.9% | +119.4% | +103.6% | +135.5% |
| 10-Year ReturnCumulative with dividends | +207.8% | +90.0% | +122.6% | +197.2% | +52.2% | +481.2% |
| CAGR (3Y)Annualised 3-year return | -12.0% | +13.3% | +8.0% | +5.0% | -1.3% | +33.7% |
Risk & Volatility
Evenly matched — MXC and JPM each lead in 1 of 2 comparable metrics.
Risk & Volatility
MXC is the less volatile stock with a -0.87 beta — it tends to amplify market swings less than JPM's 0.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs MXC's 48.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.87x | -0.39x | -0.32x | -0.27x | -0.30x | 0.87x |
| 52-Week HighHighest price in past year | $16.48 | $176.41 | $214.71 | $135.87 | $52.71 | $338.09 |
| 52-Week LowLowest price in past year | $7.66 | $105.53 | $142.40 | $85.57 | $31.45 | $269.72 |
| % of 52W HighCurrent price vs 52-week peak | +48.0% | +78.1% | +80.9% | +79.3% | +79.9% | +96.2% |
| RSI (14)Momentum oscillator 0–100 | 40.1 | 36.2 | 36.6 | 38.4 | 38.2 | 72.1 |
| Avg Volume (50D)Average daily shares traded | 12K | 13.7M | 8.0M | 7.0M | 12.7M | 7.4M |
Analyst Outlook
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: XOM as "Hold", CVX as "Buy", COP as "Buy", DVN as "Buy", JPM as "Buy". Consensus price targets imply 39.5% upside for DVN (target: $59) vs 4.5% for JPM (target: $340). For income investors, CVX offers the higher dividend yield at 3.96% vs MXC's 1.25%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $170.08 | $200.13 | $132.92 | $58.77 | $339.75 |
| # AnalystsCovering analysts | — | 55 | 53 | 52 | 64 | 61 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | +2.9% | +4.0% | +3.0% | +2.3% | +1.8% |
| Dividend StreakConsecutive years of raises | 1 | 43 | 38 | 9 | 1 | 15 |
| Dividend / ShareAnnual DPS | $0.10 | $4.00 | $6.87 | $3.19 | $0.98 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.3% | +3.5% | +3.4% | +3.8% | +4.0% | +3.8% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MXC leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
MXC vs XOM vs CVX vs COP vs DVN vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MXC or XOM or CVX or COP or DVN or JPM a better buy right now?
For growth investors, Mexco Energy Corporation (MXC) is the stronger pick with 11.
4% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). Mexco Energy Corporation (MXC) offers the better valuation at 9. 8x trailing P/E, making it the more compelling value choice. Analysts rate Chevron Corporation (CVX) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MXC or XOM or CVX or COP or DVN or JPM?
On trailing P/E, Mexco Energy Corporation (MXC) is the cheapest at 9.
8x versus Chevron Corporation at 26. 2x. On forward P/E, Devon Energy Corporation is actually cheaper at 7. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — MXC or XOM or CVX or COP or DVN or JPM?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +159.
4%, compared to +4. 8% for Mexco Energy Corporation (MXC). Over 10 years, the gap is even starker: JPM returned +481. 2% versus DVN's +52. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MXC or XOM or CVX or COP or DVN or JPM?
By beta (market sensitivity over 5 years), Mexco Energy Corporation (MXC) is the lower-risk stock at -0.
87β versus JPMorgan Chase & Co. 's 0. 87β — meaning JPM is approximately -199% more volatile than MXC relative to the S&P 500. On balance sheet safety, Mexco Energy Corporation (MXC) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — MXC or XOM or CVX or COP or DVN or JPM?
By revenue growth (latest reported year), Mexco Energy Corporation (MXC) is pulling ahead at 11.
4% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: Mexco Energy Corporation grew EPS 30. 6% year-over-year, compared to -31. 8% for Chevron Corporation. Over a 3-year CAGR, MXC leads at 3. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MXC or XOM or CVX or COP or DVN or JPM?
Mexco Energy Corporation (MXC) is the more profitable company, earning 23.
3% net margin versus 6. 7% for Chevron Corporation — meaning it keeps 23. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MXC leads at 26. 5% versus 9. 0% for CVX. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MXC or XOM or CVX or COP or DVN or JPM more undervalued right now?
On forward earnings alone, Devon Energy Corporation (DVN) trades at 7.
5x forward P/E versus 14. 6x for JPMorgan Chase & Co. — 7. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DVN: 39. 5% to $58. 77.
08Which pays a better dividend — MXC or XOM or CVX or COP or DVN or JPM?
All stocks in this comparison pay dividends.
Chevron Corporation (CVX) offers the highest yield at 4. 0%, versus 1. 3% for Mexco Energy Corporation (MXC).
09Is MXC or XOM or CVX or COP or DVN or JPM better for a retirement portfolio?
For long-horizon retirement investors, Mexco Energy Corporation (MXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
87), 1. 3% yield, +207. 8% 10Y return). Both have compounded well over 10 years (MXC: +207. 8%, JPM: +481. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MXC and XOM and CVX and COP and DVN and JPM?
These companies operate in different sectors (MXC (Energy) and XOM (Energy) and CVX (Energy) and COP (Energy) and DVN (Energy) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MXC is a small-cap deep-value stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; COP is a mid-cap deep-value stock; DVN is a mid-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.